Abstract

Fucosidosis is a lysosomal storage disorder (LSD) caused by lysosomal α-L-fucosidase deficiency. Insufficient α-L-fucosidase activity triggers accumulation of undegraded, fucosylated glycoproteins and glycolipids in various tissues. The human phenotype is heterogeneous, but progressive motor and cognitive impairments represent the most characteristic symptoms. Recently, Fuca1-deficient mice were generated by gene targeting techniques, constituting a novel animal model for human fucosidosis. These mice display widespread LSD pathology, accumulation of secondary storage material and neuroinflammation throughout the brain, as well as progressive loss of Purkinje cells. Fuca1-deficient mice and control littermates were subjected to a battery of tests detailing different aspects of motor, emotional and cognitive function. At an early stage of disease, we observed reduced exploratory activity, sensorimotor disintegration as well as impaired spatial learning and fear memory. These early markers of neurological deterioration were related to the respective stage of neuropathology using molecular genetic and immunochemical procedures. Increased expression of the lysosomal marker Lamp1 and neuroinflammation markers was observed throughout the brain, but appeared more prominent in cerebral areas in comparison to cerebellum of Fuca1-deficient mice. This is consistent with impaired behaviors putatively related to early disruptions of motor and cognitive circuits particularly involving cerebral cortex, basal ganglia, and hippocampus. Thus, Fuca1-deficient mice represent a practical and promising fucosidosis model, which can be utilized for pathogenetic and therapeutic studies.

Highlights

  • Fucosidosis is an inborn error of metabolism that belongs to the family of lysosomal storage diseases (LSDs; Durand et al, 1966; Van Hoof and Hers, 1968)

  • We assessed the expression of markers relevant for lysosomal storage disorder (LSD) pathogenesis, reflecting enlargement of the lysosomal system, neuroinflammation, myelination, neuronal density and secondary storage

  • We demonstrate behavioral alterations in Fuca1deficient mice that coincide with early signs of neuropathology

Read more

Summary

Introduction

Fucosidosis is an inborn error of metabolism that belongs to the family of lysosomal storage diseases (LSDs; Durand et al, 1966; Van Hoof and Hers, 1968). It is an extremely rare disorder of which only around 120 cases have been reported worldwide. The disease is caused by mutations in the FUCA1 gene, which encodes the expression of lysosomal α-L-fucosidase (Willems et al, 1999). Insufficient activity of this exoglycosidase triggers accumulation of undegraded, fucosylated glycoproteins and glycolipids in various tissues, the brain. The detrimental disease course eventually leads to cachexia and often to early death within the first decade of life (Willems et al, 1999)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call